Swiss National Bank’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | – | Sell |
-406,100
| Closed | -$18.8M | – | 2539 |
|
2019
Q2 | $18.8M | Buy |
406,100
+37,200
| +10% | +$1.72M | 0.02% | 597 |
|
2019
Q1 | $8.99M | Buy |
368,900
+11,800
| +3% | +$288K | 0.01% | 774 |
|
2018
Q4 | $5.09M | Buy |
357,100
+8,100
| +2% | +$115K | 0.01% | 972 |
|
2018
Q3 | $5.31M | Buy |
349,000
+5,600
| +2% | +$85.1K | 0.01% | 1079 |
|
2018
Q2 | $5.76M | Buy |
343,400
+17,800
| +5% | +$299K | 0.01% | 999 |
|
2018
Q1 | $5.31M | Buy |
325,600
+16,900
| +5% | +$276K | 0.01% | 1010 |
|
2017
Q4 | $3.95M | Buy |
308,700
+6,300
| +2% | +$80.6K | ﹤0.01% | 1209 |
|
2017
Q3 | $3.72M | Buy |
302,400
+35,000
| +13% | +$431K | ﹤0.01% | 1205 |
|
2017
Q2 | $2.24M | Buy |
267,400
+17,400
| +7% | +$146K | ﹤0.01% | 1517 |
|
2017
Q1 | $2.24M | Buy |
250,000
+8,200
| +3% | +$73.3K | ﹤0.01% | 1493 |
|
2016
Q4 | $2.13M | Sell |
241,800
-13,900
| -5% | -$122K | ﹤0.01% | 1508 |
|
2016
Q3 | $1.73M | Buy |
255,700
+44,000
| +21% | +$297K | ﹤0.01% | 1608 |
|
2016
Q2 | $754K | Sell |
211,700
-23,100
| -10% | -$82.3K | ﹤0.01% | 2125 |
|
2016
Q1 | $669K | Buy |
234,800
+43,600
| +23% | +$124K | ﹤0.01% | 2150 |
|
2015
Q4 | $807K | Hold |
191,200
| – | – | ﹤0.01% | 1967 |
|
2015
Q3 | $872K | Buy |
191,200
+24,900
| +15% | +$114K | ﹤0.01% | 1849 |
|
2015
Q2 | $1.2M | Buy |
166,300
+22,300
| +15% | +$161K | ﹤0.01% | 1684 |
|
2015
Q1 | $1.06M | Hold |
144,000
| – | – | ﹤0.01% | 1734 |
|
2014
Q4 | $681K | Buy |
144,000
+6,300
| +5% | +$29.8K | ﹤0.01% | 1973 |
|
2014
Q3 | $492K | Hold |
137,700
| – | – | ﹤0.01% | 2113 |
|
2014
Q2 | $628K | Hold |
137,700
| – | – | ﹤0.01% | 2031 |
|
2014
Q1 | $647K | Buy |
137,700
+28,300
| +26% | +$133K | ﹤0.01% | 1985 |
|
2013
Q4 | $548K | Hold |
109,400
| – | – | ﹤0.01% | 1927 |
|
2013
Q3 | $680K | Sell |
109,400
-4,400
| -4% | -$27.3K | ﹤0.01% | 1726 |
|
2013
Q2 | $517K | Buy |
+113,800
| New | +$517K | ﹤0.01% | 1893 |
|